Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Oncoimmunology|April 11, 2022
Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)Meichen Li, Xue Hou, Ke Sai, et al.Frontiers in Microbiology|April 21, 2025
Gut microbiota characteristics in neonatal respiratory distress syndrome and the therapeutic potential of probiotics in recoveryYongcheng Fu, Xiujuan Wang, Lintao Nie, et al.Journal for Immunotherapy of Cancer|June 18, 2021
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancerLibin Zhang, Yanhui Chen, Han Wang, et al.Breast Cancer Research and Treatment|April 21, 2023
Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatmentChi Xu, Yahui Wang, Yuanyuan Hong, et al.NPJ Precision Oncology|January 14, 2022
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockadeShuhang Wang, Pei Yuan, Beibei Mao, et al.Translational Oncology|November 22, 2020
Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinomaLu Yang, Jing Zhang, Yane Song, et al.Oncotargets and Therapy|May 12, 2021
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung AdenocarcinomaHao Wang, Shanhao Chen, Die Meng, et al.Genome Medicine|November 4, 2021
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancerZhihao Lu, Huan Chen, Xi Jiao, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.Ebiomedicine|November 28, 2021
Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohortQian Zhan, Chenlei Wen, Yi Zhao, et al.Pageof 4